Biotech

All Articles

Atea's COVID antiviral falls short to halt hospital stays in period 3

.Atea Pharmaceuticals' antiviral has stopped working yet another COVID-19 test, however the biotech ...

Neurocrine's bid to conserve mental illness prospect stops working

.Neurocrine Biosciences' mental illness course pivot has neglected. The biotech was not able to dupl...

Sanofi pays $110M upfront for late-stage radioligand treatment

.Sanofi has actually created an overdue access to the radioligand celebration, paying out one hundre...

F 2G brings up $100M for second try to obtain new antifungal to market

.After F2G's 1st effort to get a new lesson of antifungal to market was actually derailed by the FDA...

Moderna targets $1.1 B in R&ampD spending slices, drops 5 plans surrounded by earnings pressures

.Moderna has promised to reduce R&ampD costs by $1.1 billion by 2027. The choice to shrink the budge...

Sanofi's $80M bet on Pivot dystrophy medication finishes in period 3 go bust

.Just 4 months after Sanofi wager $80 million in upfront cash money on Key Therapeutics' losmapimod,...

Oncternal assets drains 60% surrounded by layoffs, test discontinuations

.Cancer business Oncternal Therapeutics is actually folding all its own professional tests as well a...

Roche is carrying out hopes that its own injectable excessive weight prospect can inevitably illustrate 25% weight reduction in late-stage test

.Roche is actually storing out chances that its injectable excessive weight possibility might at som...

Novo Nordisk hails 'outstanding' weight loss result for dual-acting oral drug in early trial

.Novo Nordisk has actually lifted the top on a phase 1 trial of its oral amylin as well as GLP-1 rec...

AbbVie files a claim against BeiGene over blood cancer medicine secret method

.Just a couple of brief full weeks after winning an FDA Fast lane tag for its investigational BTK de...